Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Frailty Is Associated with Increased One-Year Mortality in Patients with Newly Diagnosed Diffuse Large-B-Cell Lymphoma: A Population-Based Study

Abi Vijenthira, MD, Lee Mozessohn, MD, Chenthila Nagamuthu, MPH, Ning Liu, Danielle Blunt, MD, Shabbir Alibhai, MD MSc, Anca Prica, MD, Matthew C. Cheung, MDMSc

Blood (2020) 136 (Supplement 1): 34–37.

https://doi.org/10.1182/blood-2020-140585

Published: 2020

Journal Articles

Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients

Abi Vijenthira, MD, Inna Gong, MD, Thomas A Fox, BSc, MSc, MRCP, Stephen Booth, Gordon Cook, MB ChB, PhD, Bruno Fattizzo, MD, Fernando Martín Moro, Jerome Razanamahery, MD, John Riches, MD PhD, Jeffrey I. Zwicker, MD, Rushad Patell, MBBS, Marie Christiane Vekemans, Lydia Scarfo, Thomas Chatzikonstantinou, Halil Yildiz, MD, Raphael Lattenist, MD, Ioannis Mantzaris, MD MS, William Wood, MD, Lisa K. Hicks, MD MSc

Blood (2020) 136 (Supplement 1): 39–41.

https://doi.org/10.1182/blood-2020-141235

Published: 2020

Journal Articles

Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma

Abi Vijenthira, MD, Kelvin Chan, MD PhD, Matthew Cheung, MD MS, FRCP, Anca Prica, MD

Blood (2018) 132 (Supplement 1): 2248.

https://doi.org/10.1182/blood-2018-99-113103

Published: 2018

Journal Articles

Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid

Abi Vijenthira, MD, Devyani Premkumar, Richard A. Wells, MD DPhil, Jeannie Callum, MD, Yulia Lin, MD, Lisa Chodirker, MD, Martha Lenis, Alexandre Mamedov, Rena Buckstein, MD FRCPC

Blood (2017) 130 (Supplement 1): 1691.

https://doi.org/10.1182/blood.V130.Suppl_1.1691.1691

Published: 2017

Journal Articles

Is Prior Rituximab Exposure Associated with a Difference in Outcomes in Relapsed Low-Grade Lymphomas Retreated with Rituximab in Comparison to Rituximab NaïVe Patients?

Abi Vijenthira, MD, Manjula Mangati, Michael Crump, MD, Vishal Kukreti, MD, John Kuruvilla, MD, Rodger Tiedemann, MD PhD, Christine Chen, MD, Anca Prica, MD

Blood (2016) 128 (22): 1795.

https://doi.org/10.1182/blood.V128.22.1795.1795

Published: 2016

Journal Articles

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Abi Vijenthira, MD, Matthew C Cheung, MD, Chai Wye Phua, MD, Kelvin Chan, Joanna Graczyk, MD, Rena Buckstein, MD, Anca Prica, MD

Blood (2016) 128 (22): 1183.

https://doi.org/10.1182/blood.V128.22.1183.1183

Published: 2016

NARROW

Frailty Is Associated with Increased One-Year Mortality in Patients with Newly Diagnosed Diffuse Large-B-Cell Lymphoma: A Population-Based Study

Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients

Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma

Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid

Is Prior Rituximab Exposure Associated with a Difference in Outcomes in Relapsed Low-Grade Lymphomas Retreated with Rituximab in Comparison to Rituximab NaïVe Patients?

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Email alerts

ASH Publications

American Society of Hematology

Frailty Is Associated with Increased One-Year Mortality in Patients with Newly Diagnosed Diffuse Large-B-Cell Lymphoma: A Population-Based Study

Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients

Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma

Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid

Is Prior Rituximab Exposure Associated with a Difference in Outcomes in Relapsed Low-Grade Lymphomas Retreated with Rituximab in Comparison to Rituximab NaïVe Patients?

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only